Found: 1481
Select item for more details and to access through your institution.
Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?
- Published in:
- Rheumatology, 2024, v. 63, n. 7, p. 1957, doi. 10.1093/rheumatology/kead515
- By:
- Publication type:
- Article
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 583, doi. 10.1007/s40744-024-00656-3
- By:
- Publication type:
- Article
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial.
- Published in:
- Pediatric Rheumatology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12969-024-00989-x
- By:
- Publication type:
- Article
Some Drugs Have Two Faces: Paradoxical Colitis in a Patient with Psoriatic Arthritis Previously Treated with Etanercept and IL-17 Inhibitors.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 5, p. 1602, doi. 10.1007/s10620-024-08380-2
- By:
- Publication type:
- Article
Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost‐savings.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 5, p. 795, doi. 10.1111/imj.16296
- By:
- Publication type:
- Article
Time to flare in giant cell arteritis and polymyalgia rheumatica: analysis from a single‐centre Australian practice.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 5, p. 838, doi. 10.1111/imj.16400
- By:
- Publication type:
- Article
Multifocal leukoencephalopathy in a patient medicated with etanercept and methotrexate for rheumatoid arthritis.
- Published in:
- Zeitschrift für Rheumatologie, 2024, v. 83, n. 4, p. 297, doi. 10.1007/s00393-023-01430-6
- By:
- Publication type:
- Article
Atorvastatin, etanercept and the nephrogenic cardiac sympathetic remodeling in chronic renal failure rats.
- Published in:
- Journal of Geriatric Cardiology, 2024, v. 21, n. 4, p. 443, doi. 10.26599/1671-5411.2024.04.007
- By:
- Publication type:
- Article
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures.
- Published in:
- Rheumatology, 2024, v. 63, n. 4, p. 1015, doi. 10.1093/rheumatology/kead321
- By:
- Publication type:
- Article
Apical fibrobullous lung disease in spondyloarthritis patients with biologic DMARDs indication.
- Published in:
- Rheumatology, 2024, v. 63, n. 4, p. 1147, doi. 10.1093/rheumatology/kead361
- By:
- Publication type:
- Article
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 2, p. 331, doi. 10.1007/s40744-023-00633-2
- By:
- Publication type:
- Article
Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 2, p. 307, doi. 10.1093/mr/road027
- By:
- Publication type:
- Article
A Bayesian Network Meta-Analysis of the Effect of Targeted Therapies on the Total Length of Hospital Stay in Children with Drug-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Syndrome.
- Published in:
- Pediatric Allergy, Immunology & Pulmonology, 2024, v. 37, n. 1, p. 22, doi. 10.1089/ped.2023.0129
- By:
- Publication type:
- Article
Peri-Transplant Inflammation and Long-Term Diabetes Outcomes Were Not Impacted by Either Etanercept or Alpha-1-Antitrypsin Treatment in Islet Autotransplant Recipients.
- Published in:
- Transplant International, 2024, p. 1, doi. 10.3389/ti.2024.12320
- By:
- Publication type:
- Article
Expert Perspective: Diagnostic Approach to the Autoinflammatory Diseases.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 2, p. 166, doi. 10.1002/art.42690
- By:
- Publication type:
- Article
Adalimumab exhibits superiority over etanercept in terms of a numerically higher response rate and equivalent adverse events: A real-world finding.
- Published in:
- Immunity, Inflammation & Disease, 2024, v. 12, n. 2, p. 1, doi. 10.1002/iid3.1166
- By:
- Publication type:
- Article
Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 2, p. 248, doi. 10.3390/ph17020248
- By:
- Publication type:
- Article
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA).
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA).
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.
- Published in:
- Rheumatology International, 2024, v. 44, n. 2, p. 249, doi. 10.1007/s00296-023-05455-7
- By:
- Publication type:
- Article
Peri-Transplant Inflammation and Long-Term Diabetes Outcomes Were Not Impacted by Either Etanercept or Alpha-1-Antitrypsin Treatment in Islet Autotransplant Recipients.
- Published in:
- Transplant International, 2024, v. 37, p. 1, doi. 10.3389/ti.2024.12320
- By:
- Publication type:
- Article
Etanercept Combined with Glucocorticoid and Gamma Globulin for Treating Children with Toxic Epidermal Necrolysis: A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
TNF Inhibitors for Rheumatoid Arthritis.
- Published in:
- MEDSURG Nursing, 2024, v. 33, n. 1, p. 20, doi. 10.62116/MSJ.2024.33.1.20
- By:
- Publication type:
- Article
Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 1, p. 1, doi. 10.1093/rap/rkae014
- By:
- Publication type:
- Article
Clinical Characteristics and Short-term Outcomes of Paediatric Patients with Chronic Recurrent Multifocal Osteomyelitis.
- Published in:
- Journal of the Child / Çocuk Dergisi, 2023, v. 23, n. 4, p. 334, doi. 10.26650/jchild.2023.1253446
- By:
- Publication type:
- Article
Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA.
- Published in:
- Rheumatology, 2023, v. 62, n. 12, p. 3849, doi. 10.1093/rheumatology/kead127
- By:
- Publication type:
- Article
The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study.
- Published in:
- Rheumatology, 2023, v. 62, n. 12, p. 3962, doi. 10.1093/rheumatology/kead318
- By:
- Publication type:
- Article
Correction: Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Real-world retention rates of biologics in patients with rheumatoid arthritis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48537-z
- By:
- Publication type:
- Article
Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40222-5
- By:
- Publication type:
- Article
Single Dose of Etanercept Injection: A Game Changer in Toxic Epidermal Necrolysis: A Case Series.
- Published in:
- Journal of Clinical & Diagnostic Research, 2023, v. 17, n. 11, p. 1, doi. 10.7860/JCDR/2023/62912.18615
- By:
- Publication type:
- Article
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.
- Published in:
- Rheumatology, 2023, v. 62, n. 11, p. 3672, doi. 10.1093/rheumatology/kead110
- By:
- Publication type:
- Article
The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 10, p. 2777, doi. 10.1007/s10067-023-06659-9
- By:
- Publication type:
- Article
Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Validation of a Test System Based on Enzyme-Linked Immunosorbent Assay for the Evaluation of Etanercept Pharmacokinetics in Patients.
- Published in:
- Pharmaceutical Chemistry Journal, 2023, v. 57, n. 7, p. 1095, doi. 10.1007/s11094-023-02989-9
- By:
- Publication type:
- Article
Focal facial myositis—a paraneoplastic syndrome?
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Effectiveness and Persistence in SB4‐ and Reference Etanercept–Treated Rheumatoid Arthritis Patients in Ordinary Clinical Practice in Norway.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 9, p. 1986, doi. 10.1002/acr.25092
- By:
- Publication type:
- Article
Uptake and Spending on Biosimilar Infliximab and Etanercept After New Start and Switching Policies in Canada: An Interrupted Time Series Analysis.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 9, p. 2011, doi. 10.1002/acr.25099
- By:
- Publication type:
- Article
Age, Sex, Metabolic and Pharmacologic Factors May Predict Nonresponse Status to Rheumatoid Arthritis Therapies.
- Published in:
- In Vivo, 2023, v. 37, n. 5, p. 2387, doi. 10.21873/invivo.13344
- By:
- Publication type:
- Article
Biologic Therapies in Juvenile Idiopathic Arthritis.
- Published in:
- Medical Journal of Bakirkoy, 2023, v. 19, n. 3, p. 269, doi. 10.4274/BMJ.galenos.2023.2023.3-20
- By:
- Publication type:
- Article
Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40222-5
- By:
- Publication type:
- Article
Transcriptomic responses of peripheral blood mononuclear cells to cyclosporin and etanercept in a female infant with juvenile generalized pustular psoriasis.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 8, p. 1299, doi. 10.1111/exd.14835
- By:
- Publication type:
- Article
Incidence of septic arthritis in patients with ankylosing spondylitis and seropositive rheumatoid arthritis following TNF inhibitor therapy.
- Published in:
- Rheumatology, 2023, v. 62, n. 8, p. 2740, doi. 10.1093/rheumatology/keac721
- By:
- Publication type:
- Article
Switching between Originators and Biosimilars in Dermatology: A Systematic Review of Real-World Clinical Studies.
- Published in:
- Biologics, 2023, v. 3, n. 2, p. 95, doi. 10.3390/biologics3020006
- By:
- Publication type:
- Article
Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survival.
- Published in:
- Rheumatology, 2023, v. 62, n. 6, p. 2230, doi. 10.1093/rheumatology/keac587
- By:
- Publication type:
- Article
Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 5, p. e2315872, doi. 10.1001/jamanetworkopen.2023.15872
- By:
- Publication type:
- Article
Psoriasis: overview, treatments and implications for nursing care.
- Published in:
- British Journal of Nursing, 2023, v. 32, n. 10, p. 462, doi. 10.12968/bjon.2023.32.10.462
- By:
- Publication type:
- Article
The Concentration of Etanercept in Human Milk and Infant Outcomes.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 5, p. 712, doi. 10.3899/jrheum.220724
- By:
- Publication type:
- Article
Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 5, p. 1926, doi. 10.1093/rheumatology/keac463
- By:
- Publication type:
- Article
So behandele ich rheumatoide Arthritis bei Dialysepatienten.
- Published in:
- Zeitschrift für Rheumatologie, 2023, v. 82, n. 4, p. 325, doi. 10.1007/s00393-023-01334-5
- By:
- Publication type:
- Article